Literature DB >> 12393097

Chlamydophila pneumoniae (Chlamydia pneumoniae) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice.

R Ezzahiri1, H J M G Nelissen-Vrancken, H A J M Kurvers, F R M Stassen, I Vliegen, G E L M Grauls, M M L van Pul, P J E H M Kitslaar, C A Bruggeman.   

Abstract

OBJECTIVE: Atherosclerosis is an inflammatory process and is characterised by the presence of T-lymphocytes in the lesions. To study the role of Chlamydophila pneumoniae (C. pneumoniae) in this process and the effect of infection on T-cell influx, we infected Apo E3-Leiden mice with C. pneumoniae and investigated the effect on lesion development and T-cell influx in atherosclerotic lesions at different time points post infection (pi).
METHODS: Nine week old mice, fed an atherogenic diet, were either mock-infected or infected with C. pneumoniae and sacrificed at 1, 6 and 9 months pi. Longitudinal sections of the aortic arches of the mice were stained with hematoxylin-eosin for atherosclerotic lesion type and lesion area analysis, or with rabbit-anti-CD3(+) to detect the presence of T-cells in the atherosclerotic lesions. T-cell influx was expressed as number of T-lymphocytes/lesion area.
RESULTS: At 1 month pi, type 1, 2 and 3 lesions were present. At other time points pi, more complex lesion types 4, 5a and 5b were also present. Although infection did not influence the total lesion number or area, we observed an effect of C. pneumoniae infection on lesion type. Infection resulted in a significant shift in lesion formation from type 3 to type 4 (P=0.022) at 6 months pi, and from type 4 to type 5a (P=0.002) at 9 months pi. T-cells were observed at every time point pi. At 1 month pi, a significant increase in T-cell influx in the C. pneumoniae-infected atherosclerotic lesions was observed (P=0.0005).
CONCLUSION: This study shows that C. pneumoniae infection enhances the inflammatory process by increasing T-lymphocytes in the plaque and accelerates the formation of complex lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393097     DOI: 10.1016/s0008-6363(02)00544-8

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  11 in total

Review 1.  Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested.

Authors:  J Thomas Grayston; Robert J Belland; Gerald I Byrne; Cho Chou Kuo; Julius Schachter; Walter E Stamm; Guangming Zhong
Journal:  Pathog Dis       Date:  2014-12-04       Impact factor: 3.166

Review 2.  Infection and Atherosclerosis Development.

Authors:  Lee Ann Campbell; Michael E Rosenfeld
Journal:  Arch Med Res       Date:  2015-05-21       Impact factor: 2.235

3.  Chlamydia pneumoniae accelerates coronary artery disease progression in transgenic hyperlipidemia-genetic hypertension rat model.

Authors:  Victoria L M Herrera; Li Shen; Lyle V Lopez; Tamara Didishvili; You-Xun Zhang; Nelson Ruiz-Opazo
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

Review 4.  The role of the vascular dendritic cell network in atherosclerosis.

Authors:  Noah Alberts-Grill; Timothy L Denning; Amir Rezvan; Hanjoong Jo
Journal:  Am J Physiol Cell Physiol       Date:  2013-04-03       Impact factor: 4.249

5.  Chlamydia pneumoniae Infection and Inflammatory Diseases.

Authors:  Rebecca A Porritt; Timothy R Crother
Journal:  For Immunopathol Dis Therap       Date:  2016

6.  Antibiotics for secondary prevention of coronary heart disease.

Authors:  Naqash J Sethi; Sanam Safi; Steven Kwasi Korang; Asbjørn Hróbjartsson; Maria Skoog; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-02-23

Review 7.  Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis.

Authors:  Ayman Samir Farid; Yoichiro Horii
Journal:  Lipids Health Dis       Date:  2012-07-23       Impact factor: 3.876

8.  Chlamydia pneumoniae aggravates vein graft intimal hyperplasia in a rat model.

Authors:  Geoffrey T L Kloppenburg; Rick de Graaf; Gert E L M Grauls; Cathrien A Bruggeman; Frank R Stassen
Journal:  BMC Microbiol       Date:  2007-12-06       Impact factor: 3.605

9.  Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development.

Authors:  Min Xia; Daxin Chen; Valeria Endresz; Ildiko Faludi; Andrea Szabo; Eva Gonczol; Vijay Kakkar; Xinjie Lu
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

10.  GroEL1, a heat shock protein 60 of Chlamydia pneumoniae, impairs neovascularization by decreasing endothelial progenitor cell function.

Authors:  Yi-Wen Lin; Chun-Yao Huang; Yung-Hsiang Chen; Chun-Ming Shih; Nai-Wen Tsao; Cheng-Yen Lin; Nen-Chung Chang; Chien-Sung Tsai; Hsiao-Ya Tsai; Jui-Chi Tsai; Po-Hsun Huang; Chi-Yuan Li; Feng-Yen Lin
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.